PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS

Patent Number: CA-3037447-A1

Publication Year: 2018

Application Year: 2017

Priority Year: 2016

Jurisdictions: CA

Status: Pending

Inventors:

DAVID BRIAN KARPF HOLTEN ANDERSEN LARS HOLTEN ANDERSEN LARS KENNETT SPROGOE KENNETT SPROGØE SPROGE KENNETT SPROGEE Kennett SPROGOE KENNETT SPROGOE KENNETT SPROGOE KENNETT SPROGOE KENNETT SPROGOE KENNETT SPROGOEE KENNETT SPROGØE KENNETT SPROGØE KENNETT SPROGØE KENNETT SPROGØE KENNETT SPROGØE KENNETT SPROGØE KENNETT SPROGØE KENNETT SPROGØE KENNETT SPROGØE KENNETT SPROGØE KENNETT SPROGØE KENNETT SPROGØE KENNETT SPROGØE KENNETT SPROGØE KENNETT SPROGØE KENNETT SPROGØE KENNETT SPROGØE KENNETT SPROGØE KENNETT SPROGØE KENNETT SPROGØE KENNETT SPROGØE KENNETT КАРПФ, Дэвид Брайан КАРПФ, Дэвид Брайан HOLTEN ANDERSEN LARS HOLTEN ANDERSEN LARS HOLTEN ANDERSEN LARS HOLTEN ANDERSEN LARS HOLTEN ANDERSEN LARS HOLTEN ANDERSEN LARS HOLTEN ANDERSEN LARS HOLTEN ANDERSEN LARS HOLTEN ANDERSEN LARS HOLTEN ANDERSEN LARS HOLTEN ANDERSEN LARS HOLTEN ANDERSEN LARS HOLTEN ANDERSEN LARS HOLTEN ANDERSEN LARS HOLTEN ANDERSEN LARS HOLTEN ANDERSEN LARS HOLTEN ANDERSEN LARS HOLTEN ANDERSEN LARS HOLTEN ANDERSEN LARS HOLTEN ANDERSEN LARS HOLTEN ANDERSEN LARS HOLTEN ANDERSEN LARS HOLTEN ANDERSEN LARS HOLTEN ANDERSEN LARS HOLTEN ANDERSEN LARS HOLTEN ANDERSEN LARS HOLTEN ANDERSEN LARS KARPF DAVID BRIAN KARPF DAVID BRIAN KENNETT SPROGØE KHOLTEN-ANDERSEN LARS L. Holden-Anderson LARS HOLTEN-ANDERSEN LARS HOLTEN-ANDERSEN КАРПФ, Дэвид Брайан КАРПФ, Дэвид Брайан D.B. Kapf DAVID BRIAN KARPF DAVID BRIAN KARPF KARPF DAVID BRIAN KARPF DAVID BRIAN KARPF DAVID BRIAN KARPF DAVID BRIAN KARPF DAVID BRIAN KARPF DAVID BRIAN KARPF DAVID BRIAN KARPF DAVID BRIAN KARPF DAVID BRIAN KARPF DAVID BRIAN KARPF DAVID BRIAN KARPF DAVID BRIAN KARPF DAVID BRIAN KARPF DAVID BRIAN KARPF DAVID BRIAN KARPF DAVID BRIAN KARPF DAVID BRIAN KARPF DAVID BRIAN KARPF DAVID BRIAN KARPF DAVID BRIAN KARPF DAVID BRIAN KARPF DAVID BRIAN KARPF DAVID BRIAN KARPF DAVID BRIAN KARPF DAVID BRIAN KARPF DAVID BRIAN KARPF DAVID BRIAN KARPF DEVID BRAJAN LARS HOLTEN-ANDERSEN SPROGØE KENNETT SPROGØE KENNETT КАРПФ, Дэвид Брайан КАРПФ, Дэвид Брайан CLEEMANN FELIX CLEEMANN FELIX CLEENMANN FELIX MAITRO GUILLAUME MAITRO GUILLAUME MAITRO GUILLAUME KRUSCH MATHIAS KRUSCH MATHIAS KRUSCH MATHIAS WEGGE THOMAS WEGGE THOMAS WEGGE THOMAS ZETTLER JOACHIM ZETTLER JOACHIM ZETTLER JOACHIM

Applicants:

  1. Ascendis Pharma Bone Diseases AS
    2. [NORA names: Ascendis Pharma; Private Research]

Abstract

The present invention relates to a pharmaceutical composition comprising a PTH compound, wherein after subcutaneous administration the pharmacokinetic profile of the PTH compound exhibits a peak to trough ratio of less than 4 within one injection interval.

Patent Family Records (36)

PTH Compounds with Low Peak-To-Trough Ratios  

Ascendis Pharma Bone Diseases AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)

2024, US-20240173385-A1

PTH compounds with low peak-to-trough ratios  

Ascendis Pharma Bone Diseases AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)

2024, US-11857603-B2

PTH compounds with low peak-to-trough ratios  

Ascendis Pharma Bone Diseases AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)

2024, AU-2017336251-B2

PTH Compounds with Low Peak-To-Trough Ratios  

Ascendis Pharma Bone Diseases AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)

2023, US-20230218722-A1

PTH compounds with low peak-to-trough ratios  

Ascendis Pharma Bone Diseases AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)

2023, US-11759504-B2

PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS  

ASCENDIS PHARMA BONE DISEASES AS SPROGOE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)

2023, SI-3518961-T1

PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS  

ASCENDIS PHARMA BONE DISEASES AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)

2023, RS-64177-B1

PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS  

ASCENDIS PHARMA BONE DISEASES AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)

2023, PL-3518961-T3

PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS  

ASCENDIS PHARMA BONE DISEASES AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)

2023, LT-3518961-T

PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS  

ASCENDIS PHARMA BONE DISEASES A SPROGE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)

2023, KR-20230170810-A

PTH compounds with low peak-to-trough ratios  

아센디스 파마 본 디지즈 에이/에스 КАРПФ, Дэвид Брайан, СПРОГЕЕ, Кеннетт, ХОЛЬТЕН-АНДЕРСЕН, Ларс, (...more)

2023, KR-102611820-B1

PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS  

ASCENDIS PHARMA BONE DISEASES AS SPROGOE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)

2023, HU-E062009-T2

PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS  

ASCENDIS PHARMA BONE DISEASES AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)

2023, HR-P20230383-T1

PTH compounds with low peak-to-valley ratios  

Ascendis Pharma Bone Diseases AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)

2023, ES-2943720-T3

PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS  

Ascendis Pharma Bone Diseases AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)

2023, EP-4218795-A3

PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS  

Ascendis Pharma Bone Diseases AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)

2023, EP-4218795-A2

PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS  

Ascendis Pharma Bone Diseases AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)

2023, EP-3518961-B1

PTH compounds with low peak to trough ratios  

ASCENDIS PHARMA BONE DISEASES AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, KARPF DAVID BRIAN, (...more)

2023, DK-3518961-T3

PTH compounds with low peak-to-valley ratio  

Ascendis Pharma Bone Diseases AS SPROGOE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)

2023, CN-117257922-A

PTH compounds with low peak-to-valley ratio  

Ascendis Pharma Bone Diseases AS SPROGOEE KENNETT, L. Holden-Anderson, D.B. Kapf

2023, CN-109789188-B

PTH COMPOUNDS WITH LOW PEAK-TO-MINIMUM RATIOS  

Astsendis Farma Boun Dizizis A/S SPROGEE Kennett, KHOLTEN-ANDERSEN LARS, KARPF DEVID BRAJAN

2022, RU-2766959-C2

PTH compounds with low peak-to-trough ratios  

Ascendis Pharma Bone Diseases AS KENNETT SPROGOE, LARS HOLTEN-ANDERSEN, DAVID BRIAN KARPF

2022, JP-2022116302-A

PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS  

Ascendis Pharma Bone Diseases AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)

2020, US-20200360488-A1

PTG CONNECTIONS WITH LOW PEAK TO MINIMUM RATIO  

Асцендис Фарма Боун Дизизис А/С КАРПФ, Дэвид Брайан, СПРОГЕЕ, Кеннетт, ХОЛЬТЕН-АНДЕРСЕН, Ларс, (...more)

2020, RU-2019112919-A

PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS  

ASCENDIS PHARMA BONE DISEASES AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)

2019, ZA-201901813-B

PTH Compounds with Low Peak-To-Trough Ratios  

Ascendis Pharma Bone Diseases AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)

2019, US-20190282668-A1

PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS  

ASCENDIS PHARMA BONE DISEASES AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)

2019, SG-11201901558V-A

PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS.  

ASCENDIS PHARMA BONE DISEASES AS KENNETT SPROGØE, LARS HOLTEN-ANDERSEN, DAVID BRIAN KARPF

2019, MX-2019003182-A

PTH COMPOUNDS WITH LOW RELATIONSHIP BETWEEN PEAK AND MINIMUM LEVEL  

ASCENDIS PHARMA BONE DISEASES AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, KARPF DAVID BRIAN, (...more)

2019, MA-46345-A

PTH compound with low peak to trough ratio  

ASCENDIS PHARMA BONE DISEASES A SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)

2019, KR-20190062497-A

PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS  

Ascendis Pharma Bone Diseases AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)

2019, EP-3518961-A1

PTH compound with low peak-to-valley ratio  

Arsendis Drug Bone Disease Co Ltd SPROGOE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)

2019, CN-109789188-A

pth compounds with low peak-to-valley ratios  

ASCENDIS PHARMA BONE DISEASES AS DAVID BRIAN KARPF, KENNETT SPROGØE, LARS HOLTEN-ANDERSEN

2019, BR-112019005793-A2

PTH compounds with low peak-to-trough ratios  

Ascendis Pharma Bone Diseases AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)

2019, AU-2017336251-A1

PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS  

ASCENDIS PHARMA BONE DISEASES AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)

2018, WO-2018060312-A1

PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS

Ascendis Pharma Bone Diseases AS SPROGOE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)

2018, CA-3037447-A1

Data Provider: Digital Science

LINKS
+

External Systems

SUBJECTS
+

PATENT CATEGORIES
+

METRICS
+

Citation Metrics

Times Cited in Patents: 0external link

References to Patents: [No Data Available]

References to Publications: 0external link